Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05972343 · ClinicalTrials.gov registry record

COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients

A clinical trial of Breast Cancer and Cancer of the Breast, sponsored by Washington University School of Medicine.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT05972343 is a study of Breast Cancer and Cancer of the Breast that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 100 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05972343, a study of Breast Cancer and Cancer of the Breast, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

This is a subject registry study of patients who undergo cryoablation for their breast cancer after being determined not to be surgical candidates. Data collected as part of this registry will be used to assess the safety of percutaneous ultrasound-guided cryoablation in this population as well as provide long-term follow-up of subjects who received cryoablation.

Interventions

  • DEVICE Cryoablation

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-07-26
Est. Completion 2031-07-31

What the Registry Record Tells You About NCT05972343

The ClinicalTrials.gov registry entry for NCT05972343 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Cryoablation is the first listed.

NCT05972343 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT05972343 about?

NCT05972343 is a clinical study titled "COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients". This is a subject registry study of patients who undergo cryoablation for their breast cancer after being determined not to be surgical candidates. Data collected as part of this registry will be used to assess the safety of percutaneous ultrasound-guided cryoablation in this population as well as p...

What is the current status of trial NCT05972343?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-07-26. Estimated completion is 2031-07-31.

What conditions does trial NCT05972343 study?

This clinical trial studies the following conditions: Breast Cancer, Cancer of the Breast.

What interventions are being tested in trial NCT05972343?

The interventions under investigation include: Cryoablation (DEVICE).

Who is sponsoring clinical trial NCT05972343?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05972343 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.